Education
About Us
Working with TipRanks
Follow Us
Neurometrix (NURO)
:NURO
NURO Stock Chart & Stats
$4.58
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Neurometrix News
NURO FAQ
What was Neurometrix’s price range in the past 12 months?
Currently, no data Available
What is Neurometrix’s market cap?
Currently, no data Available
When is Neurometrix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Neurometrix’s earnings last quarter?
Currently, no data Available
Is Neurometrix overvalued?
According to Wall Street analysts Neurometrix’s price is currently Undervalued.
Does Neurometrix pay dividends?
Neurometrix does not currently pay dividends.
What is Neurometrix’s EPS estimate?
Neurometrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurometrix have?
Currently, no data Available
What happened to Neurometrix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neurometrix?
Currently, no hedge funds are holding shares in NURO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neurometrix
NeuroMetrix, Inc. is a healthcare company focused on developing and marketing innovative medical devices and technology solutions for the treatment and management of chronic conditions, particularly within neurology. The company primarily operates in the sectors of medical devices and healthcare technology. Its core products include the Quell device, a wearable neurostimulation technology for chronic pain management, and DPNCheck, a diagnostic device for diabetic peripheral neuropathy.